Æ-941, an inhibitor of angiogenesis: rationale for development in combination with induction chemotherapy/radiotherapy in patients with non-small-cell lung cancer (nsclc) Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Evans, William
  • Latreille, J
  • Batist, G
  • Falardeau, P
  • Champagne, P
  • Rivière, M
  • Dupont, E

publication date

  • September 1999